What is the ROCE (Return on Capital Employed) of Flexion Therapeutics this year?
The ROCE of Flexion Therapeutics is 0 undefined this year.
Flexion Therapeutics ROCE 2024
Flexion Therapeutics ROCE
0
Ticker
FLXN
ISIN
US33938J1060
WKN
A1XEDR
In 2024, Flexion Therapeutics's return on capital employed (ROCE) was 0, a 0% increase from the 0 ROCE in the previous year.
Flexion Therapeutics Aktienanalyse
What does Flexion Therapeutics do?
Flexion Therapeutics is a biotechnology company specializing in the development and marketing of drugs for the treatment of pain and inflammation. The company was founded in 2007 and is headquartered in Burlington, Massachusetts. Flexion Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Flexion Therapeutics's Return on Capital Employed (ROCE)
Flexion Therapeutics's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Flexion Therapeutics's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Flexion Therapeutics's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Flexion Therapeutics’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Flexion Therapeutics Stock
How has the ROCE (Return on Capital Employed) of Flexion Therapeutics developed compared to the previous year?
The ROCE of Flexion Therapeutics has increased by 0% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Flexion Therapeutics?
A high Return on Capital Employed (ROCE) indicates that Flexion Therapeutics has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Flexion Therapeutics?
A low ROCE (Return on Capital Employed) can indicate that Flexion Therapeutics has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Flexion Therapeutics impact the company?
An increase in the ROCE of Flexion Therapeutics can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Flexion Therapeutics affect the company?
A decrease in ROCE of Flexion Therapeutics can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Flexion Therapeutics?
Some factors that can affect Flexion Therapeutics's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Flexion Therapeutics so important for investors?
The ROCE of Flexion Therapeutics is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Flexion Therapeutics take to improve the ROCE?
To improve the ROCE, Flexion Therapeutics can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Flexion Therapeutics pay?
Over the past 12 months, Flexion Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Flexion Therapeutics is expected to pay a dividend of 0 USD.
What is the dividend yield of Flexion Therapeutics?
The current dividend yield of Flexion Therapeutics is .
When does Flexion Therapeutics pay dividends?
Flexion Therapeutics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Flexion Therapeutics?
Flexion Therapeutics paid dividends every year for the past 0 years.
What is the dividend of Flexion Therapeutics?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Flexion Therapeutics located?
Flexion Therapeutics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Flexion Therapeutics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Flexion Therapeutics from 6/13/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/13/2024.
When did Flexion Therapeutics pay the last dividend?
The last dividend was paid out on 6/13/2024.
What was the dividend of Flexion Therapeutics in the year 2023?
In the year 2023, Flexion Therapeutics distributed 0 USD as dividends.
In which currency does Flexion Therapeutics pay out the dividend?
The dividends of Flexion Therapeutics are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Flexion Therapeutics stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Flexion Therapeutics
Our stock analysis for Flexion Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Flexion Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Flexion Therapeutics Revenue
- Flexion Therapeutics Net Income
- Flexion Therapeutics P/E
- Flexion Therapeutics P/S
- Flexion Therapeutics EBIT
- Flexion Therapeutics Dividend
- Flexion Therapeutics Stocks
- Flexion Therapeutics Market capitalization
- Flexion Therapeutics Debt
- Flexion Therapeutics Liabilities
- Flexion Therapeutics Equity
- Flexion Therapeutics AAQS
- Flexion Therapeutics Employees
- Flexion Therapeutics ROE
- Flexion Therapeutics ROA
- Flexion Therapeutics ROCE
